Vaccine, the AstraZeneca delays? It’s a question of money. Price renegotiable from …

Raise your hand if you have not thought that in the AstraZeneca headquarters they were crazy or had drunk something very strong. In the space of a few weeks, they have struck at least three blunders, unforgivable while fighting the biggest battle in the pharmaceutical world, which will bring companies an extra $ 50 billion dowry in 2021 alone. previously provided with data m

Facebook
Twitter
LinkedIn
Pinterest
Pocket
WhatsApp

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Recent News

Editor's Pick